XCR1 and experimental autoimmune encephalomyelitis: Cody D. Moorman (36) developed CAR-T cells and CAR-Tregs targeting X-C motif chemokine receptor 1 (XCR1) (Figure 2E) on the surface of conventional type 1 dendritic cells (DC1) to suppress experimental autoimmune encephalomyelitis (EAE).